Kirr Marbach & Co’s Corteva CTVA Stock Holding History

Kirr Marbach & Co’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-117,660	Closed	-$2.77M	–	60
2020 Q1	$2.77M	Buy	+117,660	New	+$3.24M	1.18%	35

Other funds holding CTVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kirr Marbach & Co's CTVA Position: Q2 2020 in Review

Kirr Marbach & Co sold out of Corteva (CTVA) in Q2 2020, closing a stake of 117,660 shares — an estimated $2.77M sold.

Kirr Marbach & Co first reported a position in CTVA in Q1 2020 and held it in 1 quarter. The position peaked at $2.77M in Q1 2020. 920 funds tracked by Wall St. Rank hold CTVA as of Q2 2020.

Kirr Marbach & Co reported no remaining Corteva position as of Q2 2020 after selling out during the quarter.
Kirr Marbach & Co sold 117,660 Corteva shares in Q2 2020, an estimated $2.77M.
Kirr Marbach & Co first reported a position in Corteva in Q1 2020 and held it in 1 quarter.
Kirr Marbach & Co's Corteva position peaked at $2.77M in Q1 2020.
920 funds tracked by Wall St. Rank held Corteva as of Q2 2020.

Based on Kirr Marbach & Co's 13F filing for Q2 2020, filed 17 Jul 2020.